One of the hugely important takeaways of this study is that even though the therapy was applied at the site of the most significant tumor, the immune response appeared to trigger against presumably ALL tumors throughout the body.

Is that worrisome if they thought they could control bad consequences by keeping the treatment hyperlocal?